Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial.

RTHM-021682025Rieser, Nathalie M; Bitar, Raoul; Halm, Simon; Rossgoderer, Christina; Gubser, Ladina P; Thévenaz, Maeva; Kreis, Yara; von Rotz, Robin; Nordt, Carlos; Visentini, Monika; Moujaes, Flora; Engeli, Etna J E; Ort, Andres; Seifritz, Erich; Vollenweider, Franz X; Herdener, Marcus; Preller, Katrin H

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial.

EClinicalMedicine, 82, 103149

View on PubMed ↗Publisher’s paper ↗

Citation

Rieser, Nathalie M; Bitar, Raoul; Halm, Simon; Rossgoderer, Christina; Gubser, Ladina P; Thévenaz, Maeva; Kreis, Yara; von Rotz, Robin; Nordt, Carlos; Visentini, Monika; Moujaes, Flora; Engeli, Etna J E; Ort, Andres; Seifritz, Erich; Vollenweider, Franz X; Herdener, Marcus; Preller, Katrin H. (2025). Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial.. EClinicalMedicine, 82, 103149. https://doi.org/10.1016/j.eclinm.2025.103149